Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析

◆英語タイトル:Dawnrays Pharmaceutical (Holdings) Ltd (2348) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14991
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude and cefotaxime acid, among others. It also provides cephalosporin antibiotic intermediates, bulk medicines and powder for injections for therapeutic areas such as anti-allergic, digestive system, cardiovascular system and urinary system and endocrine system, among others. Dawnrays’s research and development activities are concentrated on generic drugs of system specific medicines. The company markets its products in Hong Kong and abroad. Dawnrays is headquartered in Hong Kong.

Dawnrays Pharmaceutical (Holdings) Ltd Key Recent Developments

Aug 23,2018: Dawnrays Pharmaceutical announced its interim results for the six months ended 30 June 2018

This comprehensive SWOT profile of Dawnrays Pharmaceutical (Holdings) Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dawnrays Pharmaceutical (Holdings) Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Dawnrays Pharmaceutical (Holdings) Ltd – Key Information
Dawnrays Pharmaceutical (Holdings) Ltd – Overview
Dawnrays Pharmaceutical (Holdings) Ltd – Key Employees
Dawnrays Pharmaceutical (Holdings) Ltd – Key Employee Biographies
Dawnrays Pharmaceutical (Holdings) Ltd – Key Operational Heads
Dawnrays Pharmaceutical (Holdings) Ltd – Major Products and Services
Dawnrays Pharmaceutical (Holdings) Ltd – History
Dawnrays Pharmaceutical (Holdings) Ltd – Company Statement
Dawnrays Pharmaceutical (Holdings) Ltd – Locations And Subsidiaries
Dawnrays Pharmaceutical (Holdings) Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dawnrays Pharmaceutical (Holdings) Ltd – Business Description
Dawnrays Pharmaceutical (Holdings) Ltd – Corporate Strategy
Dawnrays Pharmaceutical (Holdings) Ltd – SWOT Analysis
SWOT Analysis – Overview
Dawnrays Pharmaceutical (Holdings) Ltd – Strengths
Dawnrays Pharmaceutical (Holdings) Ltd – Weaknesses
Dawnrays Pharmaceutical (Holdings) Ltd – Opportunities
Dawnrays Pharmaceutical (Holdings) Ltd – Threats
Dawnrays Pharmaceutical (Holdings) Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Dawnrays Pharmaceutical (Holdings) Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dawnrays Pharmaceutical (Holdings) Ltd, Key Information
Dawnrays Pharmaceutical (Holdings) Ltd, Key Ratios
Dawnrays Pharmaceutical (Holdings) Ltd, Share Data
Dawnrays Pharmaceutical (Holdings) Ltd, Major Products and Services
Dawnrays Pharmaceutical (Holdings) Ltd, History
Dawnrays Pharmaceutical (Holdings) Ltd, Key Employees
Dawnrays Pharmaceutical (Holdings) Ltd, Key Employee Biographies
Dawnrays Pharmaceutical (Holdings) Ltd, Key Operational Heads
Dawnrays Pharmaceutical (Holdings) Ltd, Other Locations
Dawnrays Pharmaceutical (Holdings) Ltd, Subsidiaries
Dawnrays Pharmaceutical (Holdings) Ltd, Key Manufacturing facilities
Dawnrays Pharmaceutical (Holdings) Ltd, Key Competitors
Dawnrays Pharmaceutical (Holdings) Ltd, SWOT Analysis
Dawnrays Pharmaceutical (Holdings) Ltd, Ratios based on current share price
Dawnrays Pharmaceutical (Holdings) Ltd, Annual Ratios
Dawnrays Pharmaceutical (Holdings) Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Dawnrays Pharmaceutical (Holdings) Ltd, Performance Chart
Dawnrays Pharmaceutical (Holdings) Ltd, Ratio Charts

★海外企業調査レポート[Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Athene Annuity & Life Assurance Company of New York:企業の戦略・SWOT・財務情報
    Athene Annuity & Life Assurance Company of New York - Strategy, SWOT and Corporate Finance Report Summary Athene Annuity & Life Assurance Company of New York - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • China Huaneng Group:企業の発電所・SWOT分析2018
    China Huaneng Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Biotest Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest Pharmaceuticals Corp (Biotest Pharmaceuticals), a subsidiary of Biotest AG, is a manufacturer and distributor of of pharmaceutical and biotherapeutic products. The company offers products such as bivigam, nabi hb, hepatitis c immune globulin and plasma for further manufacturing. It o …
  • DAIS Corp (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Corps (Dais) is an alternative energy company. It provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV and NanoClea …
  • Citizen Watch Co., Ltd. (7762):企業の財務・戦略的SWOT分析
    Citizen Watch Co., Ltd. (7762) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • National Jewish Health-製薬・医療分野:企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • Firstmark Corporation:企業の戦略・SWOT・財務情報
    Firstmark Corporation - Strategy, SWOT and Corporate Finance Report Summary Firstmark Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Amcor Limited:企業の戦略・SWOT・財務情報
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vitasoy International Holdings Ltd (0345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Arbuthnot Banking Group Plc:企業の戦略・SWOT・財務情報
    Arbuthnot Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Arbuthnot Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Miromatrix Medical Inc:製品パイプライン分析
    Summary Miromatrix Medical Inc (Miromatrix Medical) is a life science company that develops regenerative medicines. The company offers MIRODERM biologic wound matrix, MIROMESH biologic matrix, liver function restoration, kidney products, diabetes treatment and cortical strut. It creates biological r …
  • Logibec Groupe Informatique Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Logibec Groupe Informatique Ltd (Logibec), a subsidiary of GI Partners LLC, is a technology company that develops, markets, implements and supports clinical and administrative information systems. The company offers administrative solutions include Espresso FMS and MMS, an integrated informa …
  • Sinochem Group:企業の戦略・SWOT・財務分析
    Sinochem Group - Strategy, SWOT and Corporate Finance Report Summary Sinochem Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • M. Dias Branco SA Ind Com de Alimentos:企業の戦略・SWOT・財務情報
    M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report Summary M. Dias Branco SA Ind Com de Alimentos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Benesse Holdings Inc (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings Inc (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Entek Energy Ltd (ETE):企業の財務・戦略的SWOT分析
    Entek Energy Ltd (ETE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Berkley Renewables Inc (BKS):企業の財務・戦略的SWOT分析
    Berkley Renewables Inc (BKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Quidel Corp (QDEL):企業の財務・戦略的SWOT分析
    Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆